These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11734725)

  • 1. Chemoprophylaxis for household contacts of index cases of invasive non-type b Haemophilus influenzae disease.
    Murray DL; Gilsdorf JR
    Pediatr Infect Dis J; 2001 Nov; 20(11):1099-100. PubMed ID: 11734725
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemophilus influenzae type b colonization in household contacts of infected and colonized children enrolled in day care.
    Li KI; Dashefsky B; Wald ER
    Pediatrics; 1986 Jul; 78(1):15-20. PubMed ID: 3487771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin prophylaxis for throat carriage of Haemophilus influenzae type b in patients with invasive disease and their contacts.
    Gilbert GL; MacInnes SJ; Guise IA
    BMJ; 1991 Jun; 302(6790):1432-5. PubMed ID: 2070109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b.
    Daum RS; Glode MP; Goldmann DA; Halsey N; Ambrosino D; Welborn C; Mather FJ; Willard JE; Sullivan B; Murray M; Johansen T
    J Pediatr; 1981 Mar; 98(3):485-91. PubMed ID: 7009819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of contacts of children in day care with invasive Haemophilus influenzae type b disease.
    Dashefsky B; Wald E; Li K
    Pediatrics; 1986 Nov; 78(5):939-41. PubMed ID: 3489921
    [No Abstract]   [Full Text] [Related]  

  • 6. Transmission of invasive Haemophilus influenzae type b disease in day care settings.
    Makintubee S; Istre GR; Ward JI
    J Pediatr; 1987 Aug; 111(2):180-6. PubMed ID: 3497249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rifampin chemoprophylaxis on carriage eradication and new acquisition of Haemophilus influenzae type b in contacts.
    Glode MP; Daum RS; Boies EG; Ballard TL; Murray M; Granoff DM
    Pediatrics; 1985 Oct; 76(4):537-42. PubMed ID: 3900905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampin alone and in combination with trimethoprim in chemoprophylaxis for infections due to Haemophilus influenzae type b.
    Glode MP; Daum RS; Halsey NA; Johansen TL; Goldmann DA; Ambrosino D; Boies E; Granoff DM
    Rev Infect Dis; 1983; 5 Suppl 3():S549-55. PubMed ID: 6605565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprophylaxis for secondary Haemophilus influenzae type b disease.
    Cartwright KA; Begg NT; Hull D
    CDR (Lond Engl Rev); 1991 Jan; 1(1):R2-6. PubMed ID: 1669742
    [No Abstract]   [Full Text] [Related]  

  • 10. Trimethoprim and rifampin in combination for chemoprophylaxis of household contacts of patients with invasive infections due to Haemophilus influenzae type b.
    Daum RS; Glode MP; Ambrosino D; Halsey N; Goldmann DA; Mather FJ; Russell R; Kamon J; Murray M; Band JD
    Antimicrob Agents Chemother; 1983 Nov; 24(5):658-62. PubMed ID: 6607027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection.
    Hay JW; Daum RS
    Pediatrics; 1987 Sep; 80(3):319-29. PubMed ID: 3114708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of chemoprophylaxis to prevent the spread of Hemophilus influenzae B in day-care facilities.
    Broome CV; Mortimer EA; Katz SL; Fleming DW; Hightower AW
    N Engl J Med; 1987 May; 316(19):1226-8. PubMed ID: 3494944
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoprophylaxis for haemophilus influenzae type b.
    BMJ; 1991 May; 302(6785):1149. PubMed ID: 1878054
    [No Abstract]   [Full Text] [Related]  

  • 14. Recommendations for the prevention of secondary Haemophilus influenzae type b (Hib) disease.
    Ladhani S; Neely F; Heath PT; Nazareth B; Roberts R; Slack MP; McVernon J; Ramsay ME
    J Infect; 2009 Jan; 58(1):3-14. PubMed ID: 19152980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of rifampin chemoprophylaxis for contacts of patients infected with Haemophilus influenzae type B.
    Green M; Li KI; Wald ER; Guerra N; Byers C
    Antimicrob Agents Chemother; 1992 Mar; 36(3):545-7. PubMed ID: 1622163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(11):170-4, 179-80. PubMed ID: 3081787
    [No Abstract]   [Full Text] [Related]  

  • 17. Spread of Haemophilus influenzae type b: recent epidemiologic and therapeutic considerations.
    Granoff DM; Daum RS
    J Pediatr; 1980 Nov; 97(5):854-60. PubMed ID: 7000999
    [No Abstract]   [Full Text] [Related]  

  • 18. Leads from the MMWR. Update: prevention of Haemophilus influenzae type b disease.
    JAMA; 1986 Apr; 255(15):1990-2. PubMed ID: 3485727
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of vaccines and antibiotic prophylaxis in contacts and cases of Haemophilus influenzae type b (Hib) disease.
    Cartwright KA; Begg NT; Rudd PT
    Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R16-7. PubMed ID: 7511459
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemophilus influenzae type b disease in an Amish population: studies of the effects of genetic factors, immunization, and rifampin prophylaxis on the course of an outbreak.
    Granoff DM; McKinney T; Boies EG; Steele NP; Oldfather J; Pandey JP; Suarez BK
    Pediatrics; 1986 Mar; 77(3):289-95. PubMed ID: 3485275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.